For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Rose Laing
Rose Laing

Rose Laing is a Christchurch GP and GP liaison and clinical lead for Collaborative Care (shared care planning) under Canterbury Clinical Network
Articles by Rose Laing
Article archive
How to Treat
Wednesday 28 May 2025, 12:50 AM
Latest news
Events
Latest issue
Most popular
That's interesting
Gallery
National Rural Health Conference 2025 Gallery